Humacyte Inc Financial Flexibility Index

Latest as of December 2025: -0.23x

Humacyte Inc financial flexibility index. Humacyte Inc (HUMA) has a Financial Flexibility Index of -0.23x as of December 2025. Free cash flow of $-26.08 Million (operating CF $-26.12 Million minus capex $39.00K) represents 0% of total liabilities ($113.26 Million).

Financial Flexibility Index

-0.23x
Free Cash Flow / Total Liabilities

Free Cash Flow

$-26.08 Million
Operating CF − Capex

Total Liabilities

$113.26 Million
USD

Capital Expenditures

$39.00K
USD

Financial Flexibility Index of Humacyte Inc (2019–2025)

Financial flexibility index of Humacyte Inc from 2019 to 2025. Historical Financial Flexibility Index trend for Humacyte Inc across 7 annual periods. Check Humacyte Inc cash flow quality index to evaluate the quality of earnings relative to operating cash generation.

Humacyte Inc Financial Flexibility Index by Year (2019–2025)

Humacyte Inc financial flexibility index by year from 2019 to 2025. Year-by-year free cash flow to debt coverage for Humacyte Inc. For the full cash flow conversion analysis, see HUMA operating cash flow.

Year Flexibility Index Free Cash Flow (USD) Operating CF Total Liabilities YoY Change
2025 -0.92x $-104.16 Million $-105.04 Million $113.26 Million ▼ -81.5%
2024 -0.51x $-96.55 Million $-98.12 Million $190.54 Million ▲ +18.2%
2023 -0.62x $-71.03 Million $-73.31 Million $114.68 Million ▲ +22.8%
2022 -0.80x $-70.08 Million $-71.13 Million $87.37 Million ▼ -62.8%
2021 -0.49x $-80.97 Million $-81.19 Million $164.36 Million ▲ +67.9%
2020 -1.53x $-55.25 Million $-55.57 Million $36.02 Million ▲ +12.1%
2019 -1.74x $-63.66 Million $-71.79 Million $36.49 Million —
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities